Why this overlooked S&P/ASX 200 stock is rallying today

This is one of the most overlooked and perhaps misunderstood companies on the S&P/ASX 200 (Index:^AXJO) (ASX: XJO). This is why the stock is running hard today.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Qube Holdings Ltd (ASX: QUB) share price jumped higher on news that NSW Ports is pouring $120 million into expanding the rail infrastructure at Port Botany.

The Qube share price jumped 1.5% to $2.68 ahead of the market close when the S&P/ASX 200 (Index:^AXJO) (ASX: XJO) index is up 0.9%.

In contrast, its peers like the Qantas Airways Limited (ASX: QAN) share price and Brambles Limited (ASX: BXB) share price are up a more modest 0.7% and 1.1%, respectively, at the time of writing.

How Qube benefits from the investment

The reason why investors are pleased with the NSW Ports' investment is because it will better connect Qube's Moorebank terminal to the docks of three terminal containers at the port.

The four-year project, which will kick-off in 2019, will create new on-dock rail capacity at Patrick's Port Botany Terminal (Qube and Brookfield own 50% of Patrick).

This will ultimately deliver one million TEU (twenty-foot equivalent units) capacity and NWS Ports said it will look to invest in two other container terminals.

The rail expansion will reduce the number of trucks needed to transport goods from the port to Qube's intermodal terminal in Moorebank, but it's not just fuel that will be saved.

Patrick and Qube are trying to automate as much of the work as possible and given the history its managers have with the unions representing dock workers, it's probably a good move from a business perspective.

Squeezing more from Moorebank

Anything that increases the efficiencies at Moorebank will be instrumental in driving QUB's share price as the terminal is the only reason why anyone would invest in the stock.

But analysts are divided on whether Qube's stock is worth buying because near-term profits do not justify the company's share price as the stock is trading on an FY19 consensus price-earnings multiple of over 34 times.

On the other hand, those that back the stock point to the strategic value of Moorebank as the asset cannot be replicated and is perfectly positioned as a gateway for goods to flow into Sydney.

I belong to the latter camp even though Qube is essentially a one-trick pony. The thing is, this race only has one pony running in it.

Motley Fool contributor Brendon Lau owns shares of Brambles Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »